CymaBay Therapeutics, Inc. Quarterly Operating Lease, Payments in USD from Q1 2019 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
CymaBay Therapeutics, Inc. annual/quarterly Operating Lease, Payments history and growth rate from Q1 2019 to Q1 2023.
  • CymaBay Therapeutics, Inc. Operating Lease, Payments for the quarter ending March 31, 2023 was $176K, a 2.92% increase year-over-year.
  • CymaBay Therapeutics, Inc. annual Operating Lease, Payments for 2023 was $762K, a 11.1% increase from 2022.
  • CymaBay Therapeutics, Inc. annual Operating Lease, Payments for 2022 was $686K, a 3% increase from 2021.
  • CymaBay Therapeutics, Inc. annual Operating Lease, Payments for 2021 was $666K, a 2.94% increase from 2020.
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2023 $176K +$5K +2.92% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-15
Q1 2022 $171K +$5K +3.01% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q1 2021 $166K +$5K +3.11% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q1 2020 $161K +$4K +2.55% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q1 2019 $157K Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.